Researchers at University College London (UCL) have discovered a new immunotherapy to fight against the hepatitis B virus (HBV), which is the most common cause of liver cancer.
Scientists at the RIKEN Center for Biosystems Dynamics Research (BDR) have been researching the processes behind cell proliferation in hopes of better treating cancer.
Professor Dietmar W Hutmacher, Director of the ARC Centre in Additive Biomanufacturing at the Queensland University of Technology, discusses how scaffold-guided tissue engineering can...